Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 13c, Raises FY Revenue Guidance
Go back to Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 13c, Raises FY Revenue Guidance| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 246.66 -2.29 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.95 | 52 Week High | $160.00 | |||
| Open | $251.38 | 52 Week Low | $95.80 | |||
| Day High | $251.38 | P/E | 45.85 | |||
| Day Low | $245.85 | EPS | $5.38 | |||
| Volume | 130,331 | |||||
